BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3065055)

  • 1. Clinical experience with intramuscular sulbactam/ampicillin in the outpatient treatment of various infections. A multicentre trial.
    Güneren MF
    Drugs; 1988; 35 Suppl 7():57-68. PubMed ID: 3065055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
    Chang ST; Chung HY; Pai SD; Lee JH
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):175S-178S. PubMed ID: 2686917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
    De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
    J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
    Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
    APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of sulbactam/ampicillin in Japan.
    Shimada K
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):171S-174S. PubMed ID: 2686916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sultamicillin experiences in the field of internal medicine.
    Hara K; Kobayashi H
    APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
    Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
    J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
    Lode H; Springsklee M
    Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
    Dajani A
    J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract.
    Geckler RW
    Clin Ther; 1994; 16(4):662-72. PubMed ID: 7982254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical and bacteriological efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating different infections].
    Strachunskiĭ LS; Novikova IuA; Prokhorenkov PI; Iakusheva LV
    Antibiot Khimioter; 1991 Jun; 36(6):18-21. PubMed ID: 1898183
    [No Abstract]   [Full Text] [Related]  

  • 16. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
    Chiodo F; Manfredi R; Zucchini A
    Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide clinical experience with sultamicillin.
    Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
    APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulbactam/ampicillin in the treatment of pediatric infections.
    Kanra G; Secmeer G; Akalin E; Ecevit Z; Calikoglu AS; Gunel M; Tarim O
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):185S-187S. PubMed ID: 2591177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.
    Löffler L; Bauernfeind A; Keyl W
    Drugs; 1988; 35 Suppl 7():46-52. PubMed ID: 3265378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
    Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.